MADISON – Companies with ties to seven states, including two from the East and West coasts, will present their business plans at the Wisconsin Life Sciences & Venture Conference, Nov. 16-17, in Madison.
The conference will be held at Madison’s Monona Terrace Community and Convention Center on Lake Monona. It is co-produced by the Wisconsin Technology Council and the UW-Madison Office of Corporate Relations. Registration is open Tuesday and Wednesday at the conference desk in the convention center.
Eleven companies from Wisconsin will be joined as presenters at the conference by three each from Michigan and Illinois, and one each from Minnesota, Missouri, Washington and Pennsylvania.
Their products and services all fall under the market umbrella of “life sciences,” which includes medical as well as agricultural and environmental applications. Presenting companies have developed medical devices or processes to enhance those devices; drug research techniques; cancer diagnostics and therapies; clinical research information systems; nanotechnology applications; and other processes to speed or enrich drug discovery and disease diagnosis.
The companies range from the early development stages to clinical stage and the revenue-producing stage.
Presenting companies from Wisconsin are: BioSystem Development, Middleton; Cellectar, Madison; EraGen Biosciences, Madison; Lucigen Corp., Madison; NeoClone, Madison; Nerites Corp., Sun Prairie; Neurognostics, Milwaukee; NovaScan, Milwaukee; OpGen, Madison; PercipEnz Technologies, Madison; Quintessence Biosciences, Madison; ZyStor Therapeutics, Milwaukee (as of January 2005; currently in Missouri).
Presenting companies from outside Wisconsin are: Afmedica, Kalamazoo, Mich.; Immune Cell Therapy, Chicago; InterRAD Medical, Minneapolis; Mirabilis Medical, Seattle; Neural Intervention Technologies, Ann Arbor, Mich.; NeuroGenomeX, Malvern, Pa.; ProNAI Therapeutics, Kalamazoo, Mich.; ZelleRx Corp., Chicago; zuChem, Chicago.
Presenters will have 12 minutes each on Tuesday, Nov. 16, to tell their stories to prospective investors and others who will attend the conference, which has been held in Madison every year but one since 1984.
In August, a study of the results of the conference over time was completed by Dr. David Ward of NorthStar Economics in Madison. (A summary of the study is posted at www.wisconsintechnologycouncil.com)
Presenting companies were selected from a larger field that applied to a conference Selection Committee comprised of experts from venture and angel capital, life science research, company formation and management, intellectual property, and patents and licensing.
Twelve companies have been invited to make poster presentations at the two-day conference. They are: Anteco Pharma, Lodi; BellBrook Labs, Madison; Cytophil, Whitefish Bay; eMetagen, Madison; GWC Technologies, Madison; Genix Therapeutics, Wheeling, Ill.; GenTel BioSurfaces, Madison; Clacon Health Solutions, Chicago; Intellignostics, St. Paul, Minn.; Marvel Medtech, Cross Plains; QRG Bioscience, Madison; 10X Technology, Libertyville, Ill.
Over time, 196 companies have presented at the Wisconsin Life Sciences & Venture Conference, and more than 20 percent have received venture or angel financing. That compares to about 1 percent of all companies nationally that receive such financing.
On the second day of the conference – Wednesday, Nov. 17 – emerging technologies from the UW-Madison campus will be on display. Throughout the conference, national-level speakers and panels will discuss the latest issues affecting drug development and regulation, market trends and Wisconsin’s investment potential. Also, receptions will be hosted by the law firm of Michael, Best and Friedrich and the “Building the New Wisconsin Economy” project. More details on those programs will follow.
For more information on the conference, including agendas, registration rates and sponsorship information, call 608-442-7557 or visit the web site at www.wisconsintechnologycouncil.com
;
